You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-PARC antibody (ab34847)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-PARC antibody
See all PARC products (5) ...

Description

Rabbit polyclonal to PARC

Tested applications

WB, IP, ELISAmore details

Cross reactivity

Reacts with

Mouse, Human

Immunogen

Synthetic peptide: FFFGDEEEDEDEAYD conjugated to KLH, corresponding to C terminal amino acids 2503 - 2517 of Human PARC

FFFGDEEE DEDEAYD

Positive control

Most cell lines expressing PARC can be used as a positive control. HeLa and NHI 3T3 cell lysates.

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 0.01% Sodium Azide
Constituents: Whole serum

Purity

Whole antiserum

Purification notes

ab34847 is monospecific antiserum processed by delipidation and defibrination followed by sterile filtration.

Clonality

Polyclonal

Isotype

IgG

Applications

Show applications key

Our Abpromise guarantee covers the use of ab34847 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • ShowHide

    WB

     WB: 1/500 - 1/1000. Dete...Read more →

    WB: 1/500 - 1/1000. Detects a band of approximately 281 kDa (predicted molecular weight: 281 kDa).

  • ShowHide

    IP

     IP: Use at an assay depe...Read more →

    IP: Use at an assay dependent dilution.

  • ShowHide

    ELISA

     ELISA: 1/2000 - 1/10000. Read more →

    ELISA: 1/2000 - 1/10000.

Target

Function

Cytoplasmic anchor protein in p53-associated protein complex. Regulates the subcellular localization of p53 and subsequent function. Seems to be part of an atypical cullin-RING-based E3 ubiquitin-protein ligase complex. In vitro, complexes of CUL9/PARC with either CUL7 or TP53 contain E3 ubiquitin-protein ligase activity.

Tissue specificity

Ubiquitously expressed in all tissues with highest expression in testis brain and kidney.

Sequence similarities

Belongs to the cullin family.
Contains 1 DOC domain.
Contains 1 IBR-type zinc finger.
Contains 2 RING-type zinc fingers.

Domain

The IBR domain is required for interaction with UBCH7 and UBCH8.

Post-translational
modifications

In vitro, self-ubiquitination in the presence of E1, E2 and ubiquitin.
Neddylated.

Cellular localization

Cytoplasm.

Target information above from: UniProt accessionQ8IWT3 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • CUL-9 antibody
  • Cul9 antibody
  • CUL9_HUMAN antibody
  • Cullin-9 antibody
  • DKFZp686G1042 antibody
  • DKFZp686P2024 antibody
  • H7AP1 antibody
  • KIAA0708 antibody
  • OTTHUMP00000039816 antibody
  • p53 associated parkin like cytoplasmic protein antibody
  • p53-associated parkin-like cytoplasmic protein antibody
  • RP3 330M21.2 antibody
  • UbcH 7 associated protein 1 antibody
  • UbcH7 associated protein 1 antibody
  • UbcH7-associated protein 1 antibody
see all

References for Anti-PARC antibody (ab34847)

ab34847 has not yet been referenced specifically in any publications.

Publishing research using ab34847? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"